Cargando…

Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress

Acute myeloid leukemia (AML) is a complex hematological malignancy characterized by extensive heterogeneity in genetics, response to therapy and long-term outcomes, making it a prototype example of development for personalized medicine. Given the accessibility to hematologic malignancy patient sampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Wei, Lam, Yi Hui, Periyasamy, Giridharan, Chuah, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910862/ https://www.ncbi.nlm.nih.gov/pubmed/35270002 http://dx.doi.org/10.3390/ijms23052863

Ejemplares similares

Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
por: Granroth, Ginna, et al.
Publicado: (2022)

Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia()
por: Lam Yi, Hui, et al.
Publicado: (2019)

Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis
por: Colombo, Anthony R., et al.
Publicado: (2018)

Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges
por: Schlenk, Richard F.
Publicado: (2023)

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
por: Chuah, Charles, et al.
Publicado: (2009)

Challenges in Treating Older Patients with Acute Myeloid Leukemia
por: Eleni, Lagadinou D., et al.
Publicado: (2010)

Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
por: Marvin-Peek, Jennifer, et al.
Publicado: (2022)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia
por: Punwani, Nathan, et al.
Publicado: (2018)

Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
por: Morita, Kiyomi, et al.
Publicado: (2020)

Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia
por: Liu, Qiao, et al.
Publicado: (2020)

Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
por: Arnone, Marlon, et al.
Publicado: (2020)

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022)

The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
por: Huang, Wanxue, et al.
Publicado: (2022)

High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics
por: Pellegrino, Maurizio, et al.
Publicado: (2018)

Significance of spatial organization of chromosomes in the progression of acute myeloid leukemia
por: Tian, Xueli, et al.
Publicado: (2017)

Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019)

Hyper-SUMOylation of ERG Is Essential for the Progression of Acute Myeloid Leukemia
por: Chen, Xu, et al.
Publicado: (2021)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

Molecular landscape and targeted therapy of acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2018)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Emerging therapies for acute myeloid leukemia
por: Saygin, Caner, et al.
Publicado: (2017)

Therapies for acute myeloid leukemia: vosaroxin
por: Sayar, Hamid, et al.
Publicado: (2017)

Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients
por: Zeng, Mingyue, et al.
Publicado: (2019)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia
por: Zeng, Zhihong, et al.
Publicado: (2017)

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
por: Green, Steven D., et al.
Publicado: (2020)

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
por: Chen, Ying, et al.
Publicado: (2023)

Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
por: Morita, Kiyomi, et al.
Publicado: (2020)

Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
por: Morita, Kiyomi, et al.
Publicado: (2021)

SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia
por: Dong, Song, et al.
Publicado: (2015)

Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level
por: Chen, Jiahao, et al.
Publicado: (2018)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

A somatic mutation in moesin drives progression into acute myeloid leukemia
por: Yuan, Ouyang, et al.
Publicado: (2022)

Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in Progress
por: Molica, Matteo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_firjhivcl0u49e19mko2srfe3v